CHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL

CHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL was reported 251 times

CHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THALAMIC STROKE 1 0.0149
1 RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION 1 0.0085
2 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0 1 0.0079
3 NASAL TURBINATE HYPERTROPHY 2 0.0053
4 CARDIAC INFECTION 3 0.0040
5 EYELID CYST 1 0.0039
6 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
7 COMPULSIVE HOARDING 1 0.0031
8 TYMPANIC MEMBRANE DISORDER 1 0.0031
9 ANION GAP DECREASED 1 0.0029
10 STAB WOUND 1 0.0028
11 CEREBRAL MASS EFFECT 1 0.0028
12 PERIODIC LIMB MOVEMENT DISORDER 1 0.0027
13 SKIN TURGOR DECREASED 1 0.0026
14 METASTATIC LYMPHOMA 1 0.0026
15 INFECTED BITE 2 0.0024
16 BANKRUPTCY 1 0.0022
17 ALLERGY TO PLANTS 1 0.0022
18 IMMUNOGLOBULINS INCREASED 1 0.0021
19 RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
20 BONE DEMINERALISATION 2 0.0019
21 MARITAL PROBLEM 1 0.0019
22 UTERINE PROLAPSE 2 0.0018
23 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
24 JUGULAR VEIN DISTENSION 1 0.0018
25 PERFUME SENSITIVITY 1 0.0018
26 PRECOCIOUS PUBERTY 1 0.0018
27 NASAL MUCOSAL DISORDER 1 0.0017
28 TRICHOTILLOMANIA 1 0.0017
29 DERMATILLOMANIA 1 0.0017
30 SCLERAL HYPERAEMIA 1 0.0015
31 JAW DISORDER 8 0.0015
32 OPHTHALMIC MIGRAINE 1 0.0014
33 BLOOD OESTROGEN DECREASED 1 0.0014
34 VASOGENIC CEREBRAL OEDEMA 1 0.0014
35 PULMONARY ARTERY STENOSIS CONGENITAL 1 0.0014
36 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
37 GINGIVAL ABSCESS 1 0.0013
38 PULMONARY VALVE STENOSIS 1 0.0013
39 TINEA PEDIS 2 0.0013
40 COMPULSIVE SEXUAL BEHAVIOUR 1 0.0012
41 BASAL GANGLIA HAEMORRHAGE 1 0.0012
42 FEAR OF FALLING 1 0.0012
43 PANCREATITIS RELAPSING 1 0.0012
44 VACCINATION COMPLICATION 1 0.0012
45 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
46 DEVICE LOOSENING 1 0.0012
47 GINGIVAL ERYTHEMA 1 0.0012
48 THALAMUS HAEMORRHAGE 1 0.0011
49 DRUG DETOXIFICATION 1 0.0011
50 GAMBLING DISORDER 3 0.0011
51 NASAL OBSTRUCTION 2 0.0011
52 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 2 0.0011
53 VASCULAR CALCIFICATION 1 0.0009
54 PRODUCT NAME CONFUSION 1 0.0009
55 PULMONARY SARCOIDOSIS 1 0.0009
56 TONSILLAR DISORDER 1 0.0009
57 TONGUE HAEMORRHAGE 1 0.0009
58 HYPERTENSIVE EMERGENCY 1 0.0008
59 PHARYNGEAL INFLAMMATION 1 0.0008
60 TOOTH EROSION 1 0.0008
61 BLOOD UREA DECREASED 1 0.0008
62 BAND SENSATION 1 0.0008
63 CARBON DIOXIDE INCREASED 1 0.0007
64 MAST CELL ACTIVATION SYNDROME 1 0.0007
65 PULMONARY PAIN 2 0.0007
66 GENITAL HERPES 1 0.0007
67 PNEUMONIA PSEUDOMONAL 1 0.0007
68 NEPHROGENIC ANAEMIA 3 0.0006
69 BRONCHIAL DISORDER 1 0.0006
70 BLOOD AMYLASE INCREASED 1 0.0006
71 ACUTE SINUSITIS 1 0.0006
72 BLOOD CHLORIDE INCREASED 1 0.0006
73 THYROIDECTOMY 1 0.0006
74 OBSESSIVE THOUGHTS 1 0.0006
75 HYPERSEXUALITY 1 0.0005
76 OESOPHAGEAL SPASM 1 0.0005
77 LYMPH NODE PAIN 1 0.0005
78 IMPULSIVE BEHAVIOUR 2 0.0005
79 CHRONIC SINUSITIS 2 0.0005
80 PARANASAL SINUS DISCOMFORT 2 0.0005
81 HYPOREFLEXIA 1 0.0005
82 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
83 PYELONEPHRITIS ACUTE 1 0.0005
84 EYELID PAIN 1 0.0005
85 COMPULSIVE SHOPPING 1 0.0005
86 CHEST INJURY 1 0.0005
87 PHARYNGEAL ERYTHEMA 1 0.0005
88 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
89 MIDDLE EAR EFFUSION 1 0.0005
90 URINARY TRACT DISORDER 2 0.0004
91 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
92 INGROWING NAIL 1 0.0004
93 ARTHROPOD BITE 3 0.0004
94 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
95 URINARY TRACT INFECTION BACTERIAL 1 0.0004
96 ANGLE CLOSURE GLAUCOMA 1 0.0004
97 INCREASED BRONCHIAL SECRETION 1 0.0004
98 MEAN CELL VOLUME INCREASED 1 0.0004
99 AORTIC ARTERIOSCLEROSIS 1 0.0004
100 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
101 NASAL DISORDER 1 0.0004
102 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
103 FOOD POISONING 2 0.0004
104 GASTROINTESTINAL INJURY 1 0.0004
105 PHARYNGEAL DISORDER 1 0.0003
106 ADENOVIRUS INFECTION 1 0.0003
107 URINE ODOUR ABNORMAL 2 0.0003
108 CEREBROVASCULAR DISORDER 1 0.0003
109 LOSS OF EMPLOYMENT 1 0.0003
110 REBOUND ACID HYPERSECRETION 1 0.0003
111 ECONOMIC PROBLEM 5 0.0003
112 EMERGENCY CARE 1 0.0003
113 SPINAL OPERATION 4 0.0003
114 PRE-EXISTING CONDITION IMPROVED 2 0.0003
115 OTITIS MEDIA 1 0.0003
116 WOUND DEHISCENCE 1 0.0003
117 PERIPHERAL COLDNESS 4 0.0003
118 RESPIRATION ABNORMAL 2 0.0003
119 APPENDICECTOMY 1 0.0003
120 MONOCYTE COUNT INCREASED 1 0.0003
121 TENDON INJURY 1 0.0003
122 PROTEIN TOTAL DECREASED 1 0.0003
123 ORAL INFECTION 1 0.0003
124 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
125 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
126 SINUS DISORDER 5 0.0003
127 ENURESIS 1 0.0002
128 SPINAL FUSION SURGERY 1 0.0002
129 THYROID FUNCTION TEST ABNORMAL 1 0.0002
130 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
131 ONYCHOMADESIS 1 0.0002
132 MUSCLE FATIGUE 1 0.0002
133 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
134 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
135 PURULENT DISCHARGE 1 0.0002
136 ONYCHOMYCOSIS 1 0.0002
137 INTENTIONAL DEVICE MISUSE 1 0.0002
138 IMPLANT SITE PAIN 1 0.0002
139 EAR DISORDER 1 0.0002
140 HIP FRACTURE 7 0.0002
141 PRODUCT DISTRIBUTION ISSUE 2 0.0002
142 ARTHRITIS INFECTIVE 1 0.0002
143 SEASONAL ALLERGY 3 0.0002
144 SKIN ABRASION 1 0.0002
145 VULVOVAGINAL PAIN 1 0.0002
146 NASAL POLYPS 1 0.0002
147 APPLICATION SITE SWELLING 1 0.0002
148 OSTEOPENIA 3 0.0002
149 DRY THROAT 2 0.0002
150 PHLEBITIS 1 0.0002
151 TEMPERATURE INTOLERANCE 2 0.0002
152 VARICOSE VEIN 1 0.0002
153 ANHEDONIA 5 0.0002
154 SENSITIVITY TO WEATHER CHANGE 1 0.0002
155 SCRATCH 2 0.0002
156 CHOKING SENSATION 1 0.0002
157 OCULAR DISCOMFORT 2 0.0002
158 PREMATURE LABOUR 1 0.0002
159 DERMATITIS CONTACT 2 0.0002
160 ELECTROLYTE IMBALANCE 2 0.0002
161 PRODUCT LABEL CONFUSION 1 0.0002
162 HEAD DISCOMFORT 3 0.0002
163 ENERGY INCREASED 1 0.0002
164 SINUS HEADACHE 1 0.0002
165 END STAGE RENAL DISEASE 3 0.0002
166 NASAL DRYNESS 1 0.0002
167 ACUTE RESPIRATORY FAILURE 3 0.0002
168 APPETITE DISORDER 1 0.0002
169 POST-TRAUMATIC STRESS DISORDER 1 0.0001
170 ABNORMAL LOSS OF WEIGHT 1 0.0001
171 HAND FRACTURE 1 0.0001
172 POOR QUALITY SLEEP 3 0.0001
173 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
174 MAJOR DEPRESSION 1 0.0001
175 ORAL DISORDER 1 0.0001
176 PSYCHIATRIC SYMPTOM 1 0.0001
177 CEREBRAL DISORDER 1 0.0001
178 GENERAL SYMPTOM 1 0.0001
179 PRODUCT AVAILABILITY ISSUE 3 0.0001
180 CHRONIC KIDNEY DISEASE 10 0.0001
181 LIPASE INCREASED 1 0.0001
182 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
183 MULTIPLE ALLERGIES 1 0.0001
184 SINUSITIS 13 0.0001
185 NASAL DISCOMFORT 1 0.0001
186 BLOOD ALBUMIN DECREASED 1 0.0001
187 RENAL CYST 1 0.0001
188 SENSORY LOSS 1 0.0001
189 MUSCLE DISORDER 1 0.0001
190 ASPHYXIA 1 0.0001
191 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
192 SPINAL COMPRESSION FRACTURE 1 0.0001
193 MUSCLE INJURY 1 0.0001
194 BLOOD UREA INCREASED 2 0.0001
195 ATRIAL SEPTAL DEFECT 1 0.0001
196 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
197 SENSATION OF FOREIGN BODY 1 0.0001
198 UTERINE PERFORATION 1 0.0001
199 PSEUDOMONAS INFECTION 1 0.0001
200 PSYCHOLOGICAL TRAUMA 1 0.0001
201 CARDIAC MURMUR 1 0.0001
202 HYSTERECTOMY 1 0.0001
203 RESPIRATORY TRACT INFECTION 3 0.0001
204 GRIP STRENGTH DECREASED 1 0.0001
205 HYPOXIA 4 0.0001
206 EAR INFECTION 3 0.0001
207 ANAL INCONTINENCE 1 0.0001
208 OROPHARYNGEAL DISCOMFORT 1 0.0001
209 LIMB INJURY 3 0.0001
210 HIDRADENITIS 1 0.0001
211 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
212 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
213 DEPRESSION 24 0.0001
214 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
215 CHOKING 2 0.0001
216 ASCITES 3 0.0001
217 LIGAMENT SPRAIN 1 0.0001
218 HAEMATOCRIT DECREASED 2 0.0001
219 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
220 PRODUCT ADMINISTRATION ERROR 2 0.0001
221 TOOTH ABSCESS 1 0.0001
222 EUPHORIC MOOD 1 0.0001
223 EAR DISCOMFORT 1 0.0001
224 SKELETAL INJURY 1 0.0001
225 HYPERBILIRUBINAEMIA 1 0.0001
226 TOOTH LOSS 2 0.0001
227 EYE DISCHARGE 1 0.0001
228 PULMONARY HYPERTENSION 2 0.0001
229 UNINTENDED PREGNANCY 1 0.0001
230 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
231 INCONTINENCE 1 0.0001
232 RENAL PAIN 1 0.0001
233 CYSTITIS 3 0.0001
234 EATING DISORDER 2 0.0001
235 BREAST PAIN 1 0.0001
236 BODY HEIGHT DECREASED 1 0.0001
237 HEREDITARY ANGIOEDEMA 1 0.0001
238 DECREASED ACTIVITY 1 0.0001
239 PHARYNGITIS STREPTOCOCCAL 1 0.0001
240 OEDEMA 5 0.0001
241 DENTAL CARIES 1 0.0001
242 FOOT DEFORMITY 1 0.0001
243 FUNGAL INFECTION 3 0.0001
244 NERVE INJURY 1 0.0001
245 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
246 SKIN INFECTION 1 0.0001
247 BLOOD CALCIUM DECREASED 1 0.0001
248 SCAB 1 0.0001
249 MICTURITION URGENCY 1 0.0001
250 OROPHARYNGEAL PAIN 8 0.0001
251 PRODUCTIVE COUGH 4 0.0001
252 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
253 BRONCHITIS 6 0.0001
254 INJECTION SITE EXTRAVASATION 1 0.0001
255 GENERALISED OEDEMA 1 0.0001
256 PHARYNGITIS 1 0.0001
257 CYST 1 0.0001
258 ILEUS 1 0.0001
259 HEPATIC FUNCTION ABNORMAL 3 0.0001
260 TOOTH EXTRACTION 1 0.0001
261 SECRETION DISCHARGE 1 0.0001
262 DYSPNOEA EXERTIONAL 3 0.0001
263 DERMATITIS ALLERGIC 1 0.0001
264 COLITIS 3 0.0001
265 INTRAOCULAR PRESSURE INCREASED 1 0.0001
266 INFUSION SITE PAIN 1 0.0001
267 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
268 SKIN ULCER 2 0.0001
269 HIATUS HERNIA 1 0.0001
270 SEDATION 2 0.0001
271 SINUS CONGESTION 1 0.0001
272 IMPAIRED GASTRIC EMPTYING 1 0.0001
273 AKATHISIA 1 0.0001
274 APPLICATION SITE RASH 1 0.0001
275 DIVERTICULITIS 2 0.0001
276 PROCEDURAL PAIN 2 0.0001
277 WOUND 2 0.0001
278 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
279 IMPAIRED QUALITY OF LIFE 1 0.0001
280 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
281 RENAL INJURY 2 0.0001
282 IMMUNODEFICIENCY 1 0.0001
283 HYPOAESTHESIA ORAL 1 0.0001
284 LACRIMATION INCREASED 2 0.0001
285 ILL-DEFINED DISORDER 4 0.0001
286 INSURANCE ISSUE 1 0.0001
287 EMOTIONAL DISORDER 2 0.0001
288 LIMB DISCOMFORT 2 0.0001
289 MUSCULOSKELETAL CHEST PAIN 1 0.0001
290 ANKLE FRACTURE 1 0.0001
291 COGNITIVE DISORDER 3 0.0001
292 COUGH 18 0.0001
293 THERAPY PARTIAL RESPONDER 1 0.0001
294 SWOLLEN TONGUE 2 0.0001
295 BONE DENSITY DECREASED 2 0.0001
296 PRODUCT USE COMPLAINT 1 0.0001
297 RESPIRATORY TRACT CONGESTION 1 0.0001
298 PREMATURE DELIVERY 1 0.0001
299 MOOD SWINGS 2 0.0001
300 MULTIPLE SCLEROSIS 3 0.0001
301 IMPAIRED HEALING 2 0.0001
302 EXPIRED PRODUCT ADMINISTERED 2 0.0001
303 INJECTION SITE PRURITUS 4 0.0001
304 TYPE 2 DIABETES MELLITUS 2 0.0001
305 CANDIDA INFECTION 1 0.0001
306 HEMIPARESIS 1 0.0001
307 CIRCULATORY COLLAPSE 1 0.0001
308 ORTHOSTATIC HYPOTENSION 1 0.0001
309 NERVOUSNESS 3 0.0001
310 LOCAL SWELLING 1 0.0001
311 SYRINGE ISSUE 1 0.0001
312 HEART RATE DECREASED 2 0.0001
313 INJURY 4 0.0001
314 LYMPHOCYTE COUNT DECREASED 1 0.0001
315 LYMPHADENOPATHY 2 0.0001
316 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
317 GALLBLADDER DISORDER 1 0.0001
318 GOUT 1 0.0001
319 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
320 INFECTION 8 0.0001
321 RESTLESS LEGS SYNDROME 1 0.0001
322 BONE DISORDER 1 0.0001
323 PANIC ATTACK 2 0.0001
324 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
325 SUICIDAL IDEATION 5 0.0001
326 ARTHROPATHY 3 0.0001
327 MIDDLE INSOMNIA 1 0.0001
328 BLISTER 3 0.0001
329 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
330 MUSCULAR WEAKNESS 6 0.0001
331 FOOT FRACTURE 1 0.0001
332 FEELING JITTERY 1 0.0001
333 MIGRAINE 5 0.0001
334 INCREASED APPETITE 1 0.0001
335 LOWER LIMB FRACTURE 1 0.0001
336 DYSTONIA 1 0.0001
337 EAR PAIN 1 0.0001
338 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
339 SKIN FISSURES 1 0.0001
340 KIDNEY INFECTION 1 0.0001
341 DISABILITY 1 0.0001
342 CONSTIPATION 11 0.0001
343 UPPER LIMB FRACTURE 1 0.0001
344 CARDIAC FAILURE CONGESTIVE 4 0.0000
345 EMOTIONAL DISTRESS 6 0.0000
346 SUICIDE ATTEMPT 3 0.0000
347 PLEURAL EFFUSION 3 0.0000
348 TASTE DISORDER 1 0.0000
349 DEVICE BREAKAGE 2 0.0000
350 OEDEMA PERIPHERAL 6 0.0000
351 VERTIGO 3 0.0000
352 NASOPHARYNGITIS 9 0.0000
353 OSTEOPOROSIS 2 0.0000
354 ILLNESS 5 0.0000
355 PRODUCT DOSE OMISSION ISSUE 14 0.0000
356 OSTEOARTHRITIS 2 0.0000
357 PLATELET COUNT DECREASED 5 0.0000
358 JOINT INJURY 1 0.0000
359 LIVER FUNCTION TEST INCREASED 1 0.0000
360 DEEP VEIN THROMBOSIS 3 0.0000
361 AMNESIA 3 0.0000
362 MENTAL DISORDER 2 0.0000
363 BLOOD CREATININE INCREASED 3 0.0000
364 PRODUCT PRESCRIBING ISSUE 1 0.0000
365 APPLICATION SITE PAIN 1 0.0000
366 RENAL FAILURE 6 0.0000
367 TOOTH DISORDER 1 0.0000
368 THROAT IRRITATION 2 0.0000
369 ASTHMA 5 0.0000
370 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
371 TINNITUS 2 0.0000
372 PERICARDIAL EFFUSION 1 0.0000
373 PNEUMONIA 14 0.0000
374 CARDIAC DISORDER 4 0.0000
375 SWELLING 4 0.0000
376 SLEEP DISORDER 3 0.0000
377 ARRHYTHMIA 2 0.0000
378 MOBILITY DECREASED 3 0.0000
379 LOCALISED INFECTION 1 0.0000
380 INTERSTITIAL LUNG DISEASE 2 0.0000
381 FIBROMYALGIA 1 0.0000
382 URINARY TRACT INFECTION 7 0.0000
383 INJECTION SITE URTICARIA 1 0.0000
384 DYSPEPSIA 4 0.0000
385 EXTRAPYRAMIDAL DISORDER 1 0.0000
386 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
387 AGEUSIA 1 0.0000
388 PNEUMONIA ASPIRATION 1 0.0000
389 LEUKOPENIA 2 0.0000
390 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
391 ABDOMINAL PAIN LOWER 1 0.0000
392 WEIGHT DECREASED 11 0.0000
393 INFLAMMATION 2 0.0000
394 ANXIETY 11 0.0000
395 DIPLOPIA 1 0.0000
396 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
397 MUSCULOSKELETAL PAIN 2 0.0000
398 APPLICATION SITE ERYTHEMA 1 0.0000
399 DRY MOUTH 3 0.0000
400 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
401 PALLOR 1 0.0000
402 MOOD ALTERED 1 0.0000
403 SKIN LESION 1 0.0000
404 INFLUENZA LIKE ILLNESS 3 0.0000
405 MEMORY IMPAIRMENT 5 0.0000
406 RESPIRATORY DISTRESS 1 0.0000
407 ANAPHYLACTIC REACTION 2 0.0000
408 TREMOR 6 0.0000
409 FEELING COLD 1 0.0000
410 SEPSIS 4 0.0000
411 HAEMOPTYSIS 1 0.0000
412 RENAL IMPAIRMENT 3 0.0000
413 TARDIVE DYSKINESIA 1 0.0000
414 FLATULENCE 2 0.0000
415 RED BLOOD CELL COUNT DECREASED 1 0.0000
416 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
417 BALANCE DISORDER 3 0.0000
418 BACK PAIN 8 0.0000
419 MUSCULOSKELETAL STIFFNESS 3 0.0000
420 DYSPHONIA 2 0.0000
421 BONE PAIN 2 0.0000
422 HEADACHE 21 0.0000
423 DEVICE ISSUE 3 0.0000
424 PREMATURE BABY 1 0.0000
425 HEPATIC FAILURE 1 0.0000
426 DISCOMFORT 2 0.0000
427 FEELING HOT 2 0.0000
428 INJECTION SITE PAIN 10 0.0000
429 INJECTION SITE RASH 1 0.0000
430 HYPERSENSITIVITY 6 0.0000
431 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
432 ASTHENIA 12 0.0000
433 PARAESTHESIA 5 0.0000
434 DYSPHAGIA 3 0.0000
435 HYPOTHYROIDISM 1 0.0000
436 CONFUSIONAL STATE 5 0.0000
437 ATRIAL FIBRILLATION 3 0.0000
438 PSORIASIS 4 0.0000
439 STAPHYLOCOCCAL INFECTION 1 0.0000
440 DECREASED APPETITE 7 0.0000
441 VIRAL INFECTION 1 0.0000
442 FALL 10 0.0000
443 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
444 FLUSHING 3 0.0000
445 CHEST DISCOMFORT 3 0.0000
446 HAEMATURIA 1 0.0000
447 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
448 GASTRIC DISORDER 1 0.0000
449 INJECTION SITE REACTION 2 0.0000
450 ABDOMINAL DISTENSION 3 0.0000
451 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
452 CRYING 1 0.0000
453 HYPERGLYCAEMIA 1 0.0000
454 DYSURIA 1 0.0000
455 INJECTION SITE MASS 1 0.0000
456 FATIGUE 21 0.0000
457 DYSGEUSIA 2 0.0000
458 INFLUENZA 3 0.0000
459 EYE SWELLING 1 0.0000
460 EPISTAXIS 2 0.0000
461 HYPOAESTHESIA 4 0.0000
462 HOT FLUSH 2 0.0000
463 UNEVALUABLE EVENT 2 0.0000
464 RHEUMATOID ARTHRITIS 3 0.0000
465 GAIT DISTURBANCE 5 0.0000
466 INJECTION SITE SWELLING 2 0.0000
467 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
468 SEIZURE 3 0.0000
469 PERIPHERAL SWELLING 4 0.0000
470 ABNORMAL BEHAVIOUR 1 0.0000
471 DISORIENTATION 1 0.0000
472 RASH 11 0.0000
473 INJECTION SITE BRUISING 2 0.0000
474 ABORTION SPONTANEOUS 1 0.0000
475 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
476 SOMNOLENCE 5 0.0000
477 DYSKINESIA 1 0.0000
478 NEUTROPHIL COUNT DECREASED 1 0.0000
479 PAIN 15 0.0000
480 LUNG NEOPLASM MALIGNANT 1 0.0000
481 INJECTION SITE ERYTHEMA 3 0.0000
482 POLLAKIURIA 1 0.0000
483 SKIN EXFOLIATION 2 0.0000
484 MYALGIA 4 0.0000
485 PRURITUS 9 0.0000
486 HYPOACUSIS 1 0.0000
487 VAGINAL HAEMORRHAGE 1 0.0000
488 CONDITION AGGRAVATED 7 0.0000
489 DYSPNOEA 13 0.0000
490 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
491 TACHYCARDIA 2 0.0000
492 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
493 COLITIS ULCERATIVE 1 0.0000
494 PULMONARY OEDEMA 1 0.0000
495 WEIGHT INCREASED 5 0.0000
496 THERAPY NON-RESPONDER 1 0.0000
497 DIZZINESS 11 0.0000
498 SKIN IRRITATION 1 0.0000
499 SKIN DISCOLOURATION 1 0.0000
500 ADVERSE EVENT 2 0.0000
501 DIARRHOEA 14 0.0000
502 RENAL DISORDER 1 0.0000
503 BLOOD CHOLESTEROL INCREASED 1 0.0000
504 PULMONARY EMBOLISM 2 0.0000
505 NEUROPATHY PERIPHERAL 2 0.0000
506 RENAL CANCER 1 0.0000
507 ANAEMIA 4 0.0000
508 RASH ERYTHEMATOUS 1 0.0000
509 DRUG INTOLERANCE 2 0.0000
510 MALAISE 9 0.0000
511 DRY EYE 1 0.0000
512 AGGRESSION 1 0.0000
513 CELLULITIS 1 0.0000
514 FLUID RETENTION 1 0.0000
515 BLOOD PRESSURE INCREASED 3 0.0000
516 HAEMOGLOBIN DECREASED 2 0.0000
517 ARTHRALGIA 8 0.0000
518 ECZEMA 1 0.0000
519 DERMATITIS ATOPIC 1 0.0000
520 PANCREATITIS 1 0.0000
521 HYPERTENSION 4 0.0000
522 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
523 DRUG EFFECT DECREASED 1 0.0000
524 DISTURBANCE IN ATTENTION 1 0.0000
525 RASH PRURITIC 1 0.0000
526 NECK PAIN 1 0.0000
527 PANCYTOPENIA 1 0.0000
528 ABDOMINAL DISCOMFORT 3 0.0000
529 OXYGEN SATURATION DECREASED 1 0.0000
530 EYE PAIN 1 0.0000
531 CEREBROVASCULAR ACCIDENT 3 0.0000
532 LETHARGY 1 0.0000
533 EYE IRRITATION 1 0.0000
534 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
535 SURGERY 1 0.0000
536 NASAL CONGESTION 1 0.0000
537 WHEEZING 1 0.0000
538 CATARACT 1 0.0000
539 IRRITABILITY 1 0.0000
540 NO ADVERSE EVENT 3 0.0000
541 NAUSEA 13 0.0000
542 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
543 BLOOD GLUCOSE INCREASED 3 0.0000
544 LOSS OF CONSCIOUSNESS 2 0.0000
545 RHINORRHOEA 1 0.0000
546 SWELLING FACE 1 0.0000
547 PRODUCT DOSE OMISSION 1 0.0000
548 ALOPECIA 3 0.0000
549 DEHYDRATION 2 0.0000
550 NEOPLASM MALIGNANT 1 0.0000
551 HYPOTENSION 3 0.0000
552 ERYTHEMA 3 0.0000
553 ABDOMINAL PAIN UPPER 3 0.0000
554 BURNING SENSATION 1 0.0000
555 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
556 THERAPY INTERRUPTED 1 0.0000
557 AGITATION 1 0.0000
558 PAIN IN EXTREMITY 4 0.0000
559 HALLUCINATION 1 0.0000
560 ACNE 1 0.0000
561 ACUTE KIDNEY INJURY 2 0.0000
562 ABDOMINAL PAIN 3 0.0000
563 ARTHRITIS 1 0.0000
564 FEELING ABNORMAL 3 0.0000
565 CARDIAC FAILURE 1 0.0000
566 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
567 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
568 COVID-19 2 0.0000
569 INSOMNIA 3 0.0000
570 ADVERSE DRUG REACTION 1 0.0000
571 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
572 MUSCLE SPASMS 2 0.0000
573 BREAST CANCER 1 0.0000
574 PRODUCT USE ISSUE 2 0.0000
575 VOMITING 5 0.0000
576 CONTUSION 1 0.0000
577 HEART RATE INCREASED 1 0.0000
578 SYNCOPE 1 0.0000
579 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
580 DRUG INEFFECTIVE 13 0.0000
581 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
582 HAEMORRHAGE 1 0.0000
583 OVERDOSE 2 0.0000
584 INCORRECT DOSE ADMINISTERED 2 0.0000
585 VISUAL IMPAIRMENT 1 0.0000
586 HYPERHIDROSIS 1 0.0000
587 NEUTROPENIA 1 0.0000
588 VISION BLURRED 1 0.0000
589 DEATH 6 0.0000
590 HOSPITALISATION 1 0.0000
591 DRUG INTERACTION 1 0.0000
592 DRUG DOSE OMISSION 1 0.0000
593 URTICARIA 1 0.0000
594 MYOCARDIAL INFARCTION 1 0.0000
595 OFF LABEL USE 5 0.0000
596 CHEST PAIN 1 0.0000
597 PYREXIA 1 0.0000